Hypokalemia
Showing 2926 - 2950 of 2,961
Metastatic Solid Tumor Trial in Memphis (Topotecan, Erlotinib)
Completed
- Metastatic Solid Tumor
-
Memphis, TennesseeThe West Clinic
Aug 18, 2011
Diabetic Neuropathies, Pain Trial in United States (DVS SR, Placebo)
Terminated
- Diabetic Neuropathies
- Pain
- DVS SR
- Placebo
-
Mesa, Arizona
- +50 more
Oct 20, 2011
The Chinese Mutation Hotspot of ENaC Causing Liddle's Syndrome
Suspended
- Hypertension
-
Beijing, Beijing, ChinaFuWai Hospital
Mar 30, 2011
Hypertension Trial in Worldwide (Irbesartan/HCTZ, Irbesartan monotherapy)
Completed
- Hypertension
- Irbesartan/HCTZ
- Irbesartan monotherapy
-
Birmingham, Alabama
- +269 more
Apr 7, 2011
Multiple Myeloma and Plasma Cell Tumor Trial in Scottsdale, Toronto (bortezomib, cyclophosphamide, dexamethasone)
Completed
- Multiple Myeloma and Plasma Cell Neoplasm
- bortezomib
- +2 more
-
Scottsdale, Arizona
- +1 more
May 13, 2011
Hypokalemia Trial in Oulu (Hydrochlorothiazide, Licorice)
Completed
- Hypokalemia
- Hydrochlorothiazide
- Licorice
-
Oulu, FinlandOulu University Hospital
Dec 10, 2009
Breast Cancer Trial in United States (Gemcitabine, Paclitaxel protein-bound particles for injectable suspension (albumin-bound))
Completed
- Breast Cancer
- Gemcitabine
- Paclitaxel protein-bound particles for injectable suspension (albumin-bound)
-
Mobile, Alabama
- +200 more
May 31, 2011
Idiopathic Hypercalciuria, Hypokalemia Caused by Thiazide Diuretics Trial in Indianapolis (Spironolactone)
Completed
- Idiopathic Hypercalciuria
- Hypokalemia Caused by Thiazide Diuretics
-
Indianapolis, IndianaIndiana University Department of Medicine, Division of Nephrolog
Dec 2, 2009
Metastatic Pancreatic Cancer Trial in United States (cetuximab, bevacizumab, gemcitabine)
Terminated
- Metastatic Pancreatic Cancer
- cetuximab
- +2 more
-
Jonesboro, Arkansas
- +15 more
May 19, 2011
Breast Cancer, Metastasis Trial in Worldwide (Dasatinib, Dasatinib 100 mg)
Completed
- Breast Cancer
- Metastasis
- Dasatinib
- Dasatinib 100 mg
-
San Francisco, California
- +22 more
Apr 21, 2011
Anemia, Leukemia, Lymphoma Trial in Scottsdale, Rochester (biological, dietary supplement, drug, other)
Completed
- Anemia
- +6 more
- darbepoetin alfa
- +3 more
-
Scottsdale, Arizona
- +1 more
May 13, 2011
Chronic Idiopathic Thrombocytopenic Purpura, Purpura, Thrombocytopenic, Idiopathic Trial in Japan (SB-497115-GR 12.5mg,
Completed
- Chronic Idiopathic Thrombocytopenic Purpura
- Purpura, Thrombocytopenic, Idiopathic
- SB-497115-GR 12.5mg
- +3 more
-
Gifu, Japan
- +6 more
Mar 29, 2011
Breast Tumors Trial (Letrozole / Temsirolimus (CCI-779), Letrozole)
Completed
- Breast Neoplasms
- Letrozole / Temsirolimus (CCI-779)
- Letrozole
- (no location specified)
Apr 13, 2011
CHF, Cardiomyopathy, Dyspnea Trial in Canada, China, United States (Fluid Status Monitoring (OptiVolâ„¢))
Completed
- Congestive Heart Failure
- +4 more
- Fluid Status Monitoring (OptiVolâ„¢)
-
Anchorage, Alaska
- +15 more
Oct 5, 2010
Acute Heart Failure Trial in Volos, Larissa (Furosemide, low-dose dopamine + low-dose furosemide)
Unknown status
- Acute Heart Failure
- Furosemide
- low-dose dopamine + low-dose furosemide
-
Volos, Magnesia, Greece
- +1 more
May 25, 2010
Polyps Trial in Cleveland (Tissue Apposition System (TAS) Device)
Completed
- Polyps
- Tissue Apposition System (TAS) Device
-
Cleveland, OhioUniversity Hospitals, Case Medical Center
Apr 20, 2010
Liver Transplantation Trial in Worldwide (Sirolimus (Rapamune), Cyclosporine or Tacrolimus)
Terminated
- Liver Transplantation
- Sirolimus (Rapamune)
- Cyclosporine or Tacrolimus
-
San Francisco, California
- +41 more
Apr 20, 2010
Oral Sodium Phosphate and Sennoside A+B Calcium Lavage for
Completed
- Colonoscopy
- (no location specified)
Feb 4, 2010
Cardiovascular Diseases, Heart Diseases Trial in Boston, Victoria (Prasugrel (CS-747), Clopidogrel)
Completed
- Cardiovascular Diseases
- Heart Diseases
- Prasugrel (CS-747)
- Clopidogrel
-
Boston, Massachusetts
- +1 more
May 21, 2010
Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma Trial in United States (Leuprolide acetate depot (LAD) 11.25 mg 3
Terminated
- Hodgkin Disease
- +3 more
- Leuprolide acetate depot (LAD) 11.25 mg 3 Month
- Matched placebo
-
Saint Louis, Missouri
- +3 more
Apr 9, 2010